Trimel Pharmaceuticals Corporation
TSX : TRL

Trimel Pharmaceuticals Corporation

February 27, 2014 16:45 ET

Trimel to Report Financial Results for 2013 and Host Conference Call to Update Investors

TORONTO, ONTARIO--(Marketwired - Feb. 27, 2014) - Trimel Pharmaceuticals Corporation (TSX:TRL) will report its financial results for the 3 month and 12 month periods ended December 31, 2013 on Wednesday, March 5th 2014 after market close.

Management of the Company will host a conference call to discuss these results and update investors on the status of its business on Thursday, March 6th 2014, at 8:30 a.m. Eastern Standard Time. Following the discussion, Trimel executives will address inquires from investment analysts.

To access the call live, please dial 416-340-2216 or 1-866-223-7781. Listeners are encouraged to dial in 10 minutes before the call begins to avoid delays.

A replay of the conference call will be available until 7:00 p.m. Eastern Standard Time on Thursday, March 13th, 2014 by dialing 905-694-9451 or 1-800-408-3053, using access code: 7051335#.

For further information regarding Trimel Pharmaceuticals Corporation, please contact Kenneth Howling, Chief Financial Officer at (416) 679-0536 or via email at ir@trimelpharmaceuticals.com.

About Trimel

Trimel is a specialty pharmaceutical company actively developing medications for male hypogonadism, female sexual dysfunction and various respiratory disorders. An NDA for CompleoTRT™, a product utilizing Trimel's licensed bioadhesive intranasal gel technology, has been accepted for review by the FDA for regulatory approval in the United States. For more information, please visit www.trimelpharmaceuticals.com.

Contact Information